Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte- macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Antineoplastic Combined Chemotherapy Protocols
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Immunoglobulin G
  • Isotretinoin
  • Neuroblastoma

abstract

  • Retrospective analysis of consecutive trials from a single center demonstrated that MoAb 3F8 + GM-CSF + CRA is effective against chemotherapy-resistant marrow MRD. Its positive impact on long-term survival can only be confirmed definitively by randomized studies.

publication date

  • September 10, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3434986

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.41.3807

PubMed ID

  • 22869886

Additional Document Info

start page

  • 3264

end page

  • 70

volume

  • 30

number

  • 26